- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Estrogen Receptor
Total 19628 results
-
MedSIRRecruitingBreast Cancer | Breast Cancer, Early-OnsetSpain, France
-
Jocelyn FitzgeraldRecruitingInterstitial CystitisUnited States
-
Accutar Biotechnology IncRecruiting
-
PfizerArvinas Estrogen Receptor, Inc.RecruitingAdvanced Breast CancerChina, Japan, United States, Taiwan, Canada, Korea, Republic of, Spain, Bulgaria, Turkey, Finland, Italy, Czechia, India, Slovakia, South Africa, Germany, Australia, Brazil, Greece, Puerto Rico, Belgium, Argentina, Switzerland, Poland, ... and more
-
Hoffmann-La RocheRecruitingBreast CancerCanada, Belgium, Korea, Republic of, United States, China, Taiwan, Mexico, Brazil, Argentina, Australia, Italy, Spain, Turkey, Thailand, United Kingdom, Poland
-
Novartis PharmaceuticalsRecruiting
-
UNICANCERNovartis; Breast Cancer Research FoundationRecruiting
-
Adrienne G. WaksEli Lilly and Company; Verastem, Inc.RecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Atossa Therapeutics, Inc.InClinRecruitingBreast Neoplasms | Invasive Breast Cancer | HER2-negative Breast Cancer | Estrogen-receptor-positive Breast CancerUnited States
-
Ente Ospedaliero Ospedali GallieraIstituto Di Ricerche Farmacologiche Mario Negri; Humanitas Hospital, ItalyRecruitingCarcinoma, Ovarian Epithelial | Low Grade Serous Adenocarcinoma of OvaryItaly
-
Canadian Cancer Trials GroupRecruiting
-
Stemline Therapeutics, Inc.RecruitingMetastatic Breast CancerUnited States, Georgia, Brazil, Bulgaria, Romania
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive TumorChina
-
Fudan UniversityRecruitingBreast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
Fudan UniversityNot yet recruiting
-
PfizerArvinas Estrogen Receptor, Inc.RecruitingBreast CancerUnited States, Canada, Spain, Italy
-
McGill University Health Centre/Research Institute...Not yet recruitingEndometriosis | FibroidsCanada
-
National Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid... and other conditionsUnited States, Puerto Rico
-
National Cancer Institute (NCI)NRG OncologyRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
PfizerArvinas Estrogen Receptor, Inc.RecruitingBreast CancerUnited States, Canada, Spain, Italy
-
Tongji HospitalRecruitingBreast Cancer | TNBC - Triple-Negative Breast Cancer | Estrogen-receptor-negative Breast CancerChina
-
Seoul National University HospitalNot yet recruitingAdvanced Breast CancerKorea, Republic of
-
Erasmus Medical CenterRecruitingER+ Breast CancerNetherlands
-
University of California, IrvineRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerUnited States
-
Eli Lilly and CompanyRecruitingBreast NeoplasmsChina, Japan, United States, Australia, Taiwan, Belgium, Canada, United Kingdom, Spain, France, Argentina, Ireland, Netherlands, Turkey, Czechia, Korea, Republic of, Finland, Hungary, Italy, Mexico, Brazil, Germany, India, Austria, Greece, Roman... and more
-
The Affiliated Hospital of Qingdao UniversityJiangsu HengRui Medicine Co., Ltd.Not yet recruiting
-
European Organisation for Research and Treatment...Breast International Group; Menarini GroupRecruitingStage IIB Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Stage III Breast CancerBelgium, Italy, Ireland, France, Germany
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Recruiting
-
Celcuity, Inc.RecruitingBreast CancerKorea, Republic of, United States, Belgium, United Kingdom, Taiwan, France, Italy, Australia, Singapore, Argentina, Canada, India, Mexico, Czechia, Spain, Austria, Bulgaria, Germany, Hungary, Poland, Brazil, Greece, Romania
-
Jose Pablo LeoneEli Lilly and Company; Translational Breast Cancer Research Consortium (TBCRC)RecruitingMale Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Negative Breast CarcinomaUnited States
-
Peking University People's HospitalNot yet recruiting
-
UNC Lineberger Comprehensive Cancer CenterRecruitingQuality of Life | Breast CancerUnited States
-
Oana DanciuNovartis PharmaceuticalsRecruitingHER2-negative Breast Cancer | Locoregional Recurrence | Hormone Receptor-positive Breast CancerUnited States
-
Emory UniversityNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast CarcinomaUnited States
-
Biyun Wang, MDRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Breast CancerChina
-
Mayo ClinicRecruitingInvasive Breast Carcinoma | Breast Adenocarcinoma | Resectable Breast CarcinomaUnited States
-
Ahon Pharmaceutical Co., Ltd.RecruitingAdvanced Breast Cancer | Female Breast CancerChina
-
Ahon Pharmaceutical Co., Ltd.RecruitingAdvanced Breast Cancer | Female Breast CancerChina
-
wang shusenRecruiting
-
Borstkanker Onderzoek GroepNovartis Pharma B.V.; BOOG Study CenterRecruitingNeoplasm, Breast | Congenital, Familial and Genetic DisordersNetherlands
-
Prof. Wolfgang JanniEli Lilly and CompanyRecruitingHormone Receptor-positive Metastatic Breast Cancer | HER2-negative Metastatic Breast CancerGermany, Switzerland
-
Universitaire Ziekenhuizen KU LeuvenRecruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | Oligometastasis | Oligometastatic Disease | Hormone Sensitive Prostate CancerBelgium
-
Gangnam Severance HospitalSeoul National UniversityRecruitingBreast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive Tumor | Premenopausal Breast Cancer | Node-positive Breast CancerKorea, Republic of
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Recruiting
-
Jonsson Comprehensive Cancer CenterNovartis; Seagen Inc.RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingBreast Cancer | Triple Negative Breast Cancer | Cardiovascular ComplicationsUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingBreast CancerUnited States, Spain, Korea, Republic of, China, France, Germany, Japan, Belgium, Italy, Australia, United Kingdom, Canada, Singapore
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
The Methodist Hospital Research InstituteEli Lilly and CompanyRecruitingHER2-negative Breast Cancer | ER-Positive Breast CancerUnited States